2022
DOI: 10.24875/gmm.21000726
|View full text |Cite
|
Sign up to set email alerts
|

Trasplante de corazón en México. Análisis de la productividad 2006-2019 y comparativa panamericana e ibérica

Abstract: Introduction:In Mexico, heart transplants (HTs) have been performed since 1988. Objective: To review Mexican productivity in terms of HT between 2006 and 2019 and compare it with that of American and Iberian Peninsula countries. Methods: Mexican information was collected from HT waiting lists (WL) and from the HTs carried out annually in the period, and was expressed as rates per million population (pmp); 2019 information was compared with that reported at the Pan American and Iberian levels. Results: In the s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
1
0
1
Order By: Relevance
“…On July 21, 1988, was the first heart transplant performed in Mexico 1 . At 31 years of this event, this document analyzes the evolution and current state of deceased organ donation and transplantation activity in Mexico over a 12-year period, from 2007 to 2018.…”
Section: Introductionmentioning
confidence: 99%
“…On July 21, 1988, was the first heart transplant performed in Mexico 1 . At 31 years of this event, this document analyzes the evolution and current state of deceased organ donation and transplantation activity in Mexico over a 12-year period, from 2007 to 2018.…”
Section: Introductionmentioning
confidence: 99%
“…En este momento, después de una cuidadosa evaluación, la opción es el reemplazo de ese órgano irreversiblemente dañado mediante el trasplante. 1,2 Eso mismo puede ocurrir con el corazón. Una falla cardiaca secundaria a lesiones estructurales congénitas o adquiridas puede evolucionar desfavorablemente sin respuesta a las opciones terapéuticas actuales.…”
unclassified